hyun_seoul said:Read four things before the headline number.
No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.
Happy to go further on any of that.
raj_cambridge said:Orforglipron is a small molecule rather than a peptide, which is the whole point: no SNAC absorption enhancer, no fasting window, no cold chain, and…
This is exactly what I could not find anywhere else.
hyun_seoul said:Read four things before the headline number.
I read this differently from hyun_seoul, on substance rather than tone. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsOne concrete data point for the thread. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.
Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Tagging this one for the weekly digest.